Related Experiment Videos
Giant-cell tumor of bone.
The Journal of Bone and Joint Surgery. American Volume
|February 1, 1986
Summary
Wide resection is associated with a lower recurrence rate for giant-cell tumors compared to curettage. Most recurrences occur within three years post-operation.
Area of Science:
- Orthopedic Surgery
- Oncology
Background:
- Giant-cell tumor (GCT) is a primary bone tumor.
- Surgical management of GCT aims to achieve local control and preserve joint function.
Purpose of the Study:
- To report the long-term outcomes of surgical management for giant-cell tumors.
- To identify factors influencing recurrence rates in GCT patients.
Main Methods:
- Retrospective analysis of 221 consecutive patients with GCT treated between 1960 and 1982.
- Comparison of recurrence rates based on surgical technique: wide resection versus curettage.
Main Results:
- The overall recurrence rate was 23% in 146 initially treated patients.
- Wide resection had a significantly lower recurrence rate (7%) compared to curettage (34%).
- All recurrences were observed within six years, with most within three years post-surgery.
Conclusions:
- Surgical technique is the most critical factor in GCT recurrence.
- Curettage and bone-grafting, prioritizing joint function, is the preferred treatment for most GCT patients.